Perceptive Advisors’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Perceptive Advisors’s Portfolio MRNS Stock Details MRNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-226,933	Closed	-$9.08M	–	128
2018 Q3	$9.08M	Hold	226,933	–	–	0.24%	59
2018 Q2	$6.42M	Hold	226,933	–	–	0.17%	67
2018 Q1	$3.47M	Hold	226,933	–	–	0.1%	85
2017 Q4	$7.41M	Sell	226,933 -136,242	-38%	-$3.67M	0.25%	63
2017 Q3	$8.53M	Buy	+363,175	New	+$4.07M	0.33%	55

Other funds holding MRNS

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

GPCM

Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

VMI

VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return

Perceptive Advisors's MRNS Position: Q4 2018 in Review

Perceptive Advisors sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q4 2018, closing a stake of 226,933 shares — an estimated $9.08M sold.

Perceptive Advisors first reported a position in MRNS in Q3 2017 and held it in 5 quarters. The position peaked at $9.08M in Q3 2018. 90 funds tracked by Wall St. Rank hold MRNS as of Q4 2018.

Perceptive Advisors reported no remaining Marinus Pharmaceuticals, Inc position as of Q4 2018 after selling out during the quarter.
Perceptive Advisors sold 226,933 Marinus Pharmaceuticals, Inc shares in Q4 2018, an estimated $9.08M.
Perceptive Advisors first reported a position in Marinus Pharmaceuticals, Inc in Q3 2017 and held it in 5 quarters.
Perceptive Advisors's Marinus Pharmaceuticals, Inc position peaked at $9.08M in Q3 2018.
90 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q4 2018.

Based on Perceptive Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.